baber/WOPTO huggingface dataset:
Patent NZ-211935-A (NZ)
Title: Absorbent product: central expanded slit layer containing superabsorbent
Inventor: PIENIAK HEINZ ALFRED
IPC: A61F13/15
Filed: 1985-04-30
Abstract: A disposable absorbent product is provided in the form of a layered structure. A first fibrous layer of resilient fibers contains superabsorbent and is superposed on a layer of hydrophilic material. The layers are unpressed and slit followed by extrusion to open the slits to provide apertures. The structure is used as the absorbent core in diapers, sanitary napkins, wound dressings and the like.
Patent NZ-221672-A (NZ)
Title: Piperidine derivatives and pharmaceutical compositions
Inventor: JENSEN LEIF HELTH
IPC: A61P25/28
Filed: 1987-09-04
Abstract: New piperidine compounds having the formula <CHEM>  wherein    at least one of R<3>, R<4>, and R<5> are <CHEM>  and the other independently are H or C1-6-alkyl,   wherein R' is H, C1-8-alkyl, phenyl, thienyl, cyclopropyl, or C1-3-alkoxymethyl; and    R<1> and R<6> independently are H or C1-6-alkyl <CHEM>  and a salt thereof with a pharmaceutically-acceptable acid. The new compounds are useful in improving the cognitive functions of the forebrain and hippocampus of mammals, and are useful in the treatment of Alzheimer's disease.
Patent NZ-235244-A (NZ)
Title: 2'-deoxy-2'-fluoro-ribonucleosides and compositions for the treatment of viral and parasitic diseases
Inventor: TISDALE SYLVIA MARGARET
IPC: A61K31/7076
Filed: 1990-09-10
Abstract: The present invention relates to 2'-fluoro substituted purine nucleosides and their use in medical therapy, particularly for the treatment of infectious diseases including influenza virus and respiratory syncytial virus infections, to methods for their preparation and to compositions containing them.
Patent NZ-238211-A (NZ)
Title: Personnel fall arrest system having brackets which undergo visually apparent deformation due to a fall
Inventor: RICHES DAVID
IPC: A62B35/04
Filed: 1991-05-21
Abstract: A personnel fall-arrest system is disclosed in which there is a flexible safety track (1) which is supported in spaced relation to a fixture (2) by brackets (5), and a coupling component (7) for connecting a worker's safety harness to said track via a safety line (8), the coupling component (7) being freely displaceable along said track. The system is characterized in that each of the brackets (5) is formed so that it becomes permanently deformed if subjected to heavy loading due to a fall, thereby signalling that the system requires to be checked and re-certified before further use.
Patent NZ-240852-A (NZ)
Title: Multistage polymers having an acid-resistant first stage copolymer and an acid-resistant, coagulable, ionically stabilised second stage copolymer; treatment of textile fibres
Inventor: ARKENS CHARLES THOMAS
IPC: D04H1/64
Filed: 1991-12-04
Abstract: A multi-stage latex binder is disclosed. The latex binder comprises one stage which enhances the stiffness of the textile fibers and another stage which controls the coagulation temperature of the latex binder. The latex binder is particularly suitable for use in battery separators.
Patent NZ-249508-A (NZ)
Title: 6-benzylpyrazolopyrimidine derivatives and medicaments
Inventor: BRU-MAGNIEZ NICOLE
IPC: A61K31/519
Filed: 1993-02-18
Abstract: The present invention relates to derivatives having the formula (I) and their tautomeric forms, as well as addition salts thereof and therapeutical utilization particularly for the treatment and prevention of cardiovascular diseases particularly for the treatment of hypertension, cardiac insufficiency, arterial wall diseases particularly atherosclerosis.
Patent NZ-255014-A (NZ)
Title: Tubular container - end flange has a pointed lip to enter cap for sealing effect
Inventor: NILSSON HUGO
IPC: B65D43/04
Filed: 1994-03-03
Abstract: PCT No. PCT/SE93/00677 Sec. 371 Date Jan. 27, 1995 Sec. 102(e) Date Jan. 27, 1995 PCT Filed Aug. 12, 1993 PCT Pub. No. WO94/04422 PCT Pub. Date Mar. 3, 1994A container (1) for a lubricant has a cap (2) for sealing off one end (4) of a cylindrical tube (2). The cap (2) shows a bottom (19), from the periphery of which extends in an axial direction a circumferential interior ring part (17), which faces the inside of said tube end (4). The cap (3) rests, with a radially extended ring part (16) connected to said interior ring part (17), upon a radial end surface of said tube end (4). According to the invention, the latter end shows a circumferential flange edge pointed obliquely inwardly towards the central part of the tube (2) and being intended to act upon an exterior circumferential bulge (24) on the outside of cap wall (17). For optimal insertion into the tube (2) and passing said edge (18), said bulge (24) downwardly forms a longer bevel (24) with a minor style in relation to said wall (17), while for optimal locking, said bulge (24) is upwardly more acutely rounded close to said lateral wall (17).
Patent NZ-263909-A (NZ)
Title: Atm network; composite cell remap between atm switching stages
Inventor: HILLER THOMAS LLOYD
IPC: H04Q3/00
Filed: 1994-03-01
Abstract: Pulse Code Modulations (PCM) signal streams are converted into Asynchronous Transfer Mode (ATM) cells for switching and transmissions across a telecommunications network. Each cell carries one PCM sample of up to 48 different voice connections, the voice connections being selected from the PCM data streams because they have a common destination. The cells are transmitted over ATM virtual paths, each path transmitting one cell every 125  mu s. The ATM signals are switched by units for switching cells (cell switching), while keeping their payload contents intact, and by units for switching the signals for individual voice connections between cells of an ATM signal (cell remapping). Advantageously, ATM transmission systems interface with PCM systems without adding appreciable delay and without requiring additional buffering. Advantageously, new voice paths can be established most of the time by using available slots in the cells of existing virtuals paths. Advantageously, large telecommunication networks can be implemented using a small number of switching units. Advantageously, a central communications network comprising stages of cell remapping interconnected by one or more stages of cell switching provides flexibility for interconnecting large access switched; the cell remapping stage may be made part of the access switch. Advantageously, an access switch comprising a cell mapping or distribution stage for assembling cells comprising PCM samples headed for a common output of the access switch are switched in a cell switch to a cell remap unit for collecting PCM samples headed for a common destination into individual cells of an ATM output stream, provides output signals that can be readily and efficiently switched by a transit network for distribution to other access switches of a large network. Advantageously, such a cell remap unit provides a key element to the implementation of an efficient large ATM voice network. For use with PCM switches, it is desirable to provide supervisory signals accompanying the PCM data. Advantageously, this arrangement permits supervisory signals to be passed within an access switch thus simplifying compatibility with existing switching systems.
Patent NZ-332037-A (NZ)
Title: Olanzapine for treating migraine pain
Inventor: SHANNON HARLAN EDGAR
IPC: A61K31/5513
Filed: 1997-03-24
Abstract: 2-methyl-4-(4-methyl-1-piperazinyl)-10H-thieno[2,3-b][1,5]benzodiazepine (olanzapine) may be used in the preparation of a medicament for treating migraine pain.
Patent NZ-335628-A (NZ)
Title: Improved expression vectors comprising a nucleic acid construct with tac and gal bacterial promoters
Inventor: SCHULTZ JODY
IPC: C12N15/74
Filed: 1997-11-07
Abstract: Disclosed are improved vectors and fermentation protocols for expression of recombinant proteins in bacterial cells.  A recombinant nucleic acid construct comprising a dual bacterial promoter operably linked too a heterologous nucleic acid that encodes a desired polypeptide, wherein the dual bacterial promotoer comprises a tac promoter component and a gal promoter component.  The construct can be used for expression of any desired protein, including enzymes useful in the enzymatic synthesis of oligosaccharides.
Patent NZ-336500-A (NZ)
Title: Reclosasble fastener assembly comprising a pair of male profiles and a pair of U-shaped closure members
Inventor: JOHNSON JAMES R
IPC: B65B9/20
Filed: 1999-06-29
Abstract: First and second closure elements 12, 22 have respectively a pair of male profiles 16, 18 and a pair of female or "U" shaped elements 24, 26 thereon, each shaped for interlocking with the other.  A thickened sealing bridge 20 between the male elements and a second thickened sealing bridge 48 between the female elements is stated are stated to allow precise sealing of the fastener element to fastener tape or to the bag walls as desired, and to keep the profiles interlocked.
Patent NZ-500838-A (NZ)
Title: Power cable joint device having pre-expanded sleeve and grease
Inventor: OSMANI SAMIR
IPC: H02G15/18
Filed: 1998-04-07
Abstract: The invention concerns a connecting cord junction or power cable joint device comprising at least a rigid tubular support element (4) including two cylindrical or conical half-supports, lubricated over most of its outer surface, with a grease which does not creep under of the pressure exerted by the retractile sleeve.  The grease is based on silicon or glycol with talc filling containing at least a pressure-resistant additive including a filler in proportions ranging from 15 to 45% by weight and/or a pressure-withstanding additive in proportions ranging from 2 to 10% by weight.  A pre-expanded and cold-retractable sleeve (5), encloses support element (4) over most of its length and on its internal end, and locking means capable of being unlocked, maintains support element (4) locked with respect to the pre-expanded sleeve (5).
Patent NZ-501286-A (NZ)
Title: Quaternary ammonium compounds as tachykinin antagonists
Inventor: MONAGHAN SANDRA MARINA
IPC: C07D453/02
Filed: 1998-06-05
Abstract: These compounds which are tachykinin antagonists are of the formula (I) wherein: R is phenyl, C3-C7 cycloalkyl or heteroaryl, each of which being optionally benzo- or C3-C7 cycloalkyl-fused and optionally substituted, including in the benzo- or C3-C7 cycloalkyl-fused portion, by from 1 to 3 substituents each independently selected from C1-C4 alkyl, fluoro(C1-C4)alkyl, C1-C4 alkoxy, fluoro(C1-C4)alkoxy, phenoxy, C2-C4 alkanoyl, halo, C1-C4 alkoxycarbonyl, C3-C7 cycloalkyl, -S(O)m(C1-C4 alkyl), cyano, -NR2R3, -S(O)mNR2R3, -NR4(C1-C4 alkanoyl) and -CONR2R3, or R is 2,3-dihydrobenzo[b]furanyl or chromanyl; R1 is H or C1-C6 alkyl; W is a direct link, methylene or ethylene; X is unbranched C2-C4 alkylene; Y is phenyl, naphthyl, benzyl, pyridyl, thienyl or C3-C7 cycloalkyl, each of which being optionally substituted by from 1 to 3 substituents each independently selected from C1-C4 alkyl, fluoro(C1-C4)alkyl, C1-C4 alkoxy, fluoro(C1-C4)alkoxy, halo and cyano; Ar is phenyl, naphthyl, benzyl, thienyl, benzo[b]thienyl or indolyl, each of which being optionally substituted by from 1 to 3 substituents each independently selected from C1-C4 alkyl, fluoro(C1-C4)alkyl, C1-C4 alkoxy, fluoro(C1-C4)alkoxy, halo and cyano, or Ar is 1,3-benzodioxolan-4 or 5-yl or 1,4-benzodioxan-5 or 6-yl; and ZA is a pharmaceutically acceptable anion.
Patent NZ-503770-A (NZ)
Title: Treatment of stress and associated symptoms by stressing blood cells and re-introducing them into the body
Inventor: TREMBLAY JOHANNE
IPC: A61K41/00
Filed: 1998-09-11
Abstract: Symptoms of stress such as elevated blood pressure in mammals are treated, and mammalian bodies are preconditioned to manifest reduced adverse reactions to subsequently encountered stresses, by injecting into the mammalian patient a small quantity of the patient's own blood which has been previously extracted and subjected extracorporeally to at least one stressor, such as ultraviolet radiation, an oxidative environment, ozone-oxygen and mild heating, especially infra-red radiation causing mild heating.  Particularly beneficial combinations of stressors are simultaneous applications of UV radiation and an ozone-oxygen gas mixture bubbled through the blood sample to provide the oxidative environment, or simultaneous application of UV radiation, ozone-oxygen gas mixtures and mild heating.  One specific use is in preconditioning against ischemic-reperfusion injury, for example prior to surgery.
Patent NZ-505818-A (NZ)
Title: Manufacture of pocket spring assemblies
Inventor: ZYSMAN MILTON
IPC: B68G9/00
Filed: 1998-12-22
Abstract: In the production of a pocket spring assembly, fabric is secured along multiple parallel seam zones so as to form a quilt defining a plurality of parallel fabric tubes connected to each other at uniformly space intervals. The tubes so formed are supported on guides extending longitudinally through the tubes, portions of the quilt are repeatedly drawn from the guides at their one ends and folds formed in each layer of fabric in the drawn off portions of the quilt, and pre-compressed coil springs are released into the pockets between each drawing of the quilt, with their axes perpendicular to both the axes of the fabric tubes and the direction of advancement of the quilt, so that secured folds in the fabric of the tubes in front of and behind the released springs retain them in the pockets. The quilt is formed in-situ on the guides, preferably using a separate web of fabric for each tube. The connections (8A) between the tubes preferably have a span perpendicular to the plane of the quilt, which is similar to the span of the connections (16) of the folds. The connections between the tubes and the connections of the folds are preferably thermal welds.
Patent NZ-508630-A (NZ)
Title: Product labelling system  for producing lables for retail products
Inventor: MCGRATH BRENT ANDREW
IPC: G06C11/04
Filed: 2000-12-05
Abstract: A labeling system for producing a physical label in a retail premises comprises: a product information database in which is stored product information representing one or more retail products available for sale from a retail premises; a product retrieval component configured to retrieve product data representing a product from the product information database; a product images database in which is stored electronic images associated with one or more products in the product information database; an image retrieval component configured to retrieve image data representing the retrieved product from the product image database and a product label generator configured to produce the physical label from the retrieved product information and the retrieved image data with the physical label being arranged for display near the retail products in the retail premise.
Patent NZ-508834-A (NZ)
Title: Means and methods for monitoring non-nucleoside reverse transcriptase inhibitor antiretroviral therapy
Inventor: WHITCOMB JEANETTE
IPC: C12Q1/68
Filed: 1999-05-26
Abstract: Disclosed are antiviral drug susceptibility and resistance tests to be used in identifying effective drug regimens for the treatment of human immunodeficiency virus (HIV) infection and acquired immunodeficiency syndrome (AIDS) and further relates to the means and methods of monitoring the clinical progression of HIV infection and its response to antiretroviral therapy, particularly non-nucleoside reverse transcriptase inhibitor therapy using phenotypic susceptibility assays or genotypic assays. Particularly disclosed are tests and test vectors relating to HIV reverse transcriptase with mutations at codon 106, 181, 190, 225, 260, 236, that cause a reduction in delavirdine susceptibility and no significant change in nevirapine susceptibility. They may have additional mutations, or more than one of the indicated mutations.
Patent NZ-509107-A (NZ)
Title: Device for applying a decorative labels to a crate
Inventor: VAN GEIJLSWIJK PETRUS JOHANNUS
IPC: B65C9/18
Filed: 1999-06-24
Abstract: A device (1) for applying a decorative label to containers such as, crates, bottles or cans (2).  The decorative comprises an image transfer label (11) supplied to the containers on a carrier strip (5).  The carrier strip (5) is pressed laterally, by means of a pressure roller (12), against the containers, which are fed past the pressure roller (12).  A heating device, such as, a hot air blower (16-19), heats the image transfer label (11) on the application side (10) of the carrier strip (5).  A flat stream of air is blown, by the hot air blower (16-19), against the line of contact between the image transfer label (11) and the container (2).  As a result of the use of highly local heating of the application side (10) of the carrier strip (5), activation of the image transfer label (11) is obtained without the carrier strip (5) or the surface of the container (2) being heated to a substantial extent.  Further, undesired stretch in the carrier strip (5) is prevented and the temperature of the image transfer label (11) can remain relatively low, so that the quality of the inks is retained and complete transfer to the containers (2) is possible.
Patent NZ-511040-A (NZ)
Title: Method for producing antibodies acting against a polypeptide that only recognises the coding nucleic acid
Inventor: ZIMMERMANN WOLFGANG
IPC: C07K16/00
Filed: 1999-11-11
Abstract: A process for the production of antibodies that react with a peptide of which the nucleic acid encoding is known, whereby the DNA encoding the polypeptide is expressed in a host cell derived from a mammal and then the expressed polypeptide is bound to a solid phase with the aid of a detection signal encoded in a vector, independently the DNA is introduced directly into a non-human animal to result in expression in the animal, said expression causes the formation of antibodies that are then reacted with the polypeptide first expressed as aforementioned, detected and then enriched.
Patent NZ-511728-A (NZ)
Title: Substances WK-5344A and WK-5344B obtained from microorganisms of the genus Streptomyces
Inventor: TAKAHASHI YOKO
IPC: C12R1/465
Filed: 1999-03-08
Abstract: Substances of the following formula; production of said substances by the culturing of microorganisms belonging to genus Streptomyces; an isolated Streptomyces sp. WK-5344 FERM BP-6668 microorganism.
Patent NZ-516808-A (NZ)
Title: Method for producing oligopolysaccharides
Inventor: SAMAIN ERIC
IPC: A61K31/702
Filed: 2000-07-07
Abstract: Disclosed is the production by microbiological process of oligosaccharides of biological interest. More particularly, the disclosure concerns a method for synthesizing in vivo oligosaccharides by internalization of an exogenous precursor in growing bacterial cells expressing adequate modifying and glycosylating genes.
Patent NZ-517170-A (NZ)
Title: Creating profiles for multiple interacting entities using merge, derive and roll-up procedures
Inventor: PATHRIA ANU K
IPC: G06Q30/00
Filed: 2000-07-25
Abstract: A computer implemented method is for generating an enhanced profile of an individual entity where the profile includes for each member of the individual entity, a single observation having at least one variable describing historical transactions pertaining to that member. The method comprises: generating at least one single entity profile of an individual entity having individual members, from historical transactions of the members of the individual entity; generating at least one multiple entity profile of at least one multiple entity defined by a combination comprising interacting individual entities, from historical transactions that include the members of each of the individual entities included in a multiple entity; and enhancing at least one single entity profile using at least one multiple entity profile to generate the enhanced profile. An example of a multiple entity is a combination of a health care provider, a health care claim processor or payor and a patient.
Patent NZ-518571-A (NZ)
Title: New use and novel N-azabicyclo-amide derivatives
Inventor: BALESTRA MICHAEL
IPC: A61K31/46
Filed: 2000-11-16
Abstract: A compound, an enantiomer or a pharmaceutically acceptable salt thereof has the formula (I) wherein: A is a group of formula (II) to (VI); D is oxygen, or sulphur; R1 is hydrogen or methyl; R2 is hydrogen, or alkyl; R3 is a group of formula (2) to (4); R4, R5, and R6 are independently hydrogen, halogen, alkyl, alkenyl, alkynyl, -CO2R7, -CN, -CF3, or Ar; Ar is an optionally substituted 5 or 6 membered aromatic or heteroaromatic ring containing 0 to 3 nitrogen, 0 or 1 oxygen and 0 or 1 sulphur or is a 8 to 10 membered fused aromatic or heteroaromatic ring system ring containing 0 to 4 nitrogen, 0 or 1 oxygen and 0 or 1 sulphur; R7 is as defined in the specification; With the proviso that Ar is not 2-, 3- or 4-pyridyl or optionally substituted phenyl, when A is a group of formula II or VI, R3 is a group of formula (2), D is oxygen, R2 and R5 is H and R6 is H, alkyl, phenyl or cyano and also provided that the compound is not N-(1-azabicyclo[2.2.2]oct-3-yl)-3-trifluoromethyl-cinnamamide, ethyl-3-[2-(3-quinclidinecarbamoyl)ethenyl]-4,6-dichloro-2-carboxylate or 2-N-butyl-N-(8-methyl-8-azabicyclo[3.2.1]-oct-3-yl)-3-phenyl-propenamide. The compound is useful for treatment or prophylaxis of human diseases or conditions in which activation of the a7 nicotinic acetylcholine receptor is beneficial such as Alzheimer's disease, learning deficit, cognition deficit, attention deficit, memory loss, Attention Deficit Hyperactivity Disorder, anxiety, schizophrenia, or mania or manic depression, Lewy Body Dementia, Parkinson's disease, Huntington's disease, Tourette's syndrome, neurodegenerative disorders in which there is loss of cholinergic synapse, jetlag, cessation of smoking, nicotine addiction including that resulting from exposure to products containing nicotine, pain, or ulcerative colitis.
Patent NZ-519059-A (NZ)
Title: Dual riser/single capillary viscometer
Inventor: KENSEY KENNETH
IPC: G01N33/487
Filed: 2000-10-12
Abstract: A blood viscosity measuring system and methods for measuring blood viscosity monitors the change in height of two, oppositely-moving, columns of blood from the circulating blood of a patient and, given the dimensions of a capillary tube (52) through which the blood flows, determines the blood viscosity over a range of shears, especially low shears. The system includes a tube set (disposable or non-disposable) that includes a pair of riser tubes (R1, R2), a capillary tube (52) of predetermined dimensions that is coupled between the riser tubes (or that forms a portion of one riser tube) and a valve mechanism (46) for controlling the circulating flow of blood from the patient into the riser tubes (R1, R2). Respective sensors monitor the movement of the columns of blood in each of the riser tubes (R1, R2) and an associated microprocessor analyzes these movements, along with the predetermined dimensions of the capillary tube (52) to determine the viscosity of the patient's circulating blood. An alternative system and method monitors only one of the two oppositely moving columns while detecting a single height position of the other one of the moving columns. From that data, along with the dimensions of a capillary tube (52) through which the blood flows, the blood viscosity over a range of shears, especially low shears, is determined.